Literature DB >> 33628581

Competing endogenous RNAs in lung cancer.

Meilian Zhao1, Jianguo Feng2, Liling Tang1.   

Abstract

Competing endogenous RNAs (ceRNAs) containing microRNA response elements can competitively interact with microRNA via miRNA response elements, which can combine non-coding RNAs with protein-coding RNAs through complex ceRNA networks. CeRNAs include non-coding RNAs (long non-coding RNAs, circular RNAs, and transcribed pseudogenes) and protein-coding RNAs (mRNAs). Molecular interactions in ceRNA networks can coordinate many biological processes; however, they may also lead to ceRNA network imbalance and thus contribute to cancer occurrence when disturbed. Recent studies indicate that many dysregulated RNAs derived from lung cancer may function as ceRNAs to regulate multitudinous biological functions for lung cancer, including tumor cell proliferation, apoptosis, growth, invasion, migration, and metastasis. This study therefore reviewed the research progress in the field of non-coding and protein-coding RNAs as ceRNAs in lung cancer, and highlighted validated ceRNAs involved in biological lung cancer functions. Furthermore, the roles of ceRNAs as novel prognostic and diagnostic biomarkers were also discussed. Interpreting the involvement of ceRNAs networks in lung cancer will provide new insight into cancer pathogenesis and treatment strategies. Copyright:
© 2021, Cancer Biology & Medicine.

Entities:  

Keywords:  CeRNA; biological functions; biomarker; lung cancer

Mesh:

Substances:

Year:  2021        PMID: 33628581      PMCID: PMC7877185          DOI: 10.20892/j.issn.2095-3941.2020.0203

Source DB:  PubMed          Journal:  Cancer Biol Med        ISSN: 2095-3941            Impact factor:   4.248


  157 in total

1.  Circular RNA circPVT1 Promotes Proliferation and Invasion Through Sponging miR-125b and Activating E2F2 Signaling in Non-Small Cell Lung Cancer.

Authors:  Xiuyuan Li; Zenglei Zhang; Hua Jiang; Qiang Li; Ruliang Wang; Hongliang Pan; Yingying Niu; Fenghai Liu; Hongmei Gu; Xingjun Fan; Jinxia Gao
Journal:  Cell Physiol Biochem       Date:  2018-12-07

Review 2.  Pseudogenes: pseudo or real functional elements?

Authors:  Wen Li; Wei Yang; Xiu-Jie Wang
Journal:  J Genet Genomics       Date:  2013-03-14       Impact factor: 4.275

Review 3.  Lung cancer: Biology and treatment options.

Authors:  Hassan Lemjabbar-Alaoui; Omer Ui Hassan; Yi-Wei Yang; Petra Buchanan
Journal:  Biochim Biophys Acta       Date:  2015-08-19

Review 4.  The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.

Authors:  Aaron N Hata; Jeffrey A Engelman; Anthony C Faber
Journal:  Cancer Discov       Date:  2015-04-20       Impact factor: 39.397

5.  The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancer.

Authors:  Ya-Long Zhang; Xue-Bing Li; Yan-Xu Hou; Nian-Zhen Fang; Jia-Cong You; Qing-Hua Zhou
Journal:  Acta Pharmacol Sin       Date:  2017-01-09       Impact factor: 6.150

6.  Long non-coding RNA JPX correlates with poor prognosis and tumor progression in non-small-cell lung cancer by interacting with miR-145-5p and CCND2.

Authors:  Meng Jin; Jie Ren; Miao Luo; Zhenxi You; Yuanyuan Fang; Yin Han; Guangcai Li; Huiguo Liu
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

Review 7.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

8.  H19 promotes non-small-cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR-17.

Authors:  Zhiwen Huang; Wei Lei; Hai-Bo Hu; Hongyan Zhang; Yehan Zhu
Journal:  J Cell Physiol       Date:  2018-04-25       Impact factor: 6.384

9.  Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a.

Authors:  Yanqin Sun; Bingshuang Hu; Qiongyao Wang; Minting Ye; Qianqian Qiu; Yuanyuan Zhou; Fanrui Zeng; Xiaomin Zhang; Ying Guo; Linlang Guo
Journal:  Cell Death Dis       Date:  2018-01-24       Impact factor: 8.469

10.  C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer.

Authors:  Hui Li; Juan Liu; Wenjie Cao; Xiaojuan Xiao; Long Liang; Feng Liu-Smith; Weiwei Wang; Hong Liu; Peng Zhou; Ruoyun Ouyang; Zhijun Yuan; Jing Liu; Mao Ye; Bin Zhang
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

View more
  8 in total

1.  A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer.

Authors:  Xu Zhang; Na Qin; Jingyi Fan; Chang Zhang; Qi Sun; Yayun Gu; Meng Zhu; Erbao Zhang; Juncheng Dai; Guangfu Jin; Hongxia Ma; Zhibin Hu; Hongbing Shen
Journal:  Cancer Biol Med       Date:  2022-09-02       Impact factor: 5.347

Review 2.  Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?

Authors:  Chao Yin; Monika Kulasekaran; Tina Roy; Brennan Decker; Sonja Alexander; Mathew Margolis; Reena C Jha; Gary M Kupfer; Aiwu R He
Journal:  Cancers (Basel)       Date:  2022-05-23       Impact factor: 6.575

3.  Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.

Authors:  Yumiao Li; Xiaoxue Yu; Yuhao Zhang; Xiaofang Wang; Linshan Zhao; Dan Liu; Guofa Zhao; Xiangpeng Gao; Jiejun Fu; Aimin Zang; Youchao Jia
Journal:  Biomed Eng Online       Date:  2021-11-24       Impact factor: 2.819

4.  Development and Validation of a Nomogram and a Comprehensive Prognostic Analysis of an LncRNA-Associated Competitive Endogenous RNA Network Based on Immune-Related Genes for Locally Advanced Rectal Cancer With Neoadjuvant Therapy.

Authors:  Fang-Ze Wei; Shi-Wen Mei; Zhi-Jie Wang; Jia-Nan Chen; Hai-Yu Shen; Fu-Qiang Zhao; Juan- Li; Ti-Xian Xiao; Qian Liu
Journal:  Front Oncol       Date:  2021-07-19       Impact factor: 6.244

5.  Identification of Differentially Expressed and Prognostic lncRNAs for the Construction of ceRNA Networks in Lung Adenocarcinoma.

Authors:  Yimeng Cui; Yaowen Cui; Ruixue Gu; Yuechao Liu; Xin Wang; Lulu Bi; Shuai Zhang; Weina Fan; Fanglin Tian; Yuning Zhan; Ningzhi Zhang; Ying Xing; Li Cai
Journal:  J Oncol       Date:  2021-12-27       Impact factor: 4.375

6.  Pseudogene AK4P1 promotes pancreatic ductal adenocarcinoma progression through relieving miR-375-mediated YAP1 degradation.

Authors:  Lang Jia; Yun Zhang; Feng Pu; Chong Yang; Shula Yang; Jinze Yu; Zihan Xu; Hongji Yang; Yu Zhou; Shikai Zhu
Journal:  Aging (Albany NY)       Date:  2022-02-27       Impact factor: 5.682

7.  Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I-III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity.

Authors:  Junkai Feng; Menglong Hu; Zongkuo Li; Guiming Hu; Yuting Han; Yan Zhang; Min Zhang; Jingli Ren
Journal:  Cells       Date:  2022-08-22       Impact factor: 7.666

Review 8.  Crosstalk among long non-coding RNA, tumor-associated macrophages and small extracellular vesicles in tumorigenesis and dissemination.

Authors:  Li-Jie Zhang; Feng Chen; Xiao-Ru Liang; Murugavel Ponnusamy; Hao Qin; Zhi-Juan Lin
Journal:  Front Oncol       Date:  2022-10-03       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.